Lavipharm S.A.
LAVI | AT
Overview
Corporate Details
- ISIN(s):
- GRS246003008
- LEI:
- 213800USC69CRPRGWJ15
- Country:
- Greece
- Address:
- AGIAS MARINAS STR, 19002 PAIANIA
- Website:
- https://lavipharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Established in 1911, Lavipharm is today an integrated group of companies engaged in the research, development, manufacturing, import, marketing and sales, wholesaling and 3PL of pharmaceutical, dermocosmetic and healthcare products in Greece, with a strong international activity. Our key features: ▪ Strong global player in pharmaceutical technologies with expertise on transdermal drug delivery systems ▪ Focus on international expansion ▪ Partner of choice for major international pharmaceutical and consumer health companies in Greece and abroad ▪ An innovator in specialty pharmacy services establishing a dynamic network across Greece ▪ Well-positioned for short, medium and long term growth
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-10 09:38 |
Registration Form
Έντυπο παροχής πληροφοριών Κανονισμού (ΕΕ) 2017/1129 (άρθρ. 1 παρ. 5 η’) αναφορ…
|
Greek (modern) | 216.3 KB | |
| 2025-07-09 09:52 |
Share Issue/Capital Change
Έντυπο παροχής πληροφοριών Κανονισμού (ΕΕ) 2017/1129 (άρθρ. 1 παρ. 4 θ΄) αναφορ…
|
Greek (modern) | 205.1 KB | |
| 2025-07-03 18:12 |
Notice of Dividend Amount
ΓΝΩΣΤΟΠΟΙΗΣΗ ΑΠΟΚΟΠΗΣ ΔΙΚΑΙΩΜΑΤΟΣ ΜΕΡΙΣΜΑΤΟΣ / ΠΛΗΡΩΜΗΣ ΜΕΡΙΣΜΑΤΟΣ/ ΠΡΟΜΕΡΙΣΜΑΤ…
|
Greek (modern) | 555.0 KB | |
| 2025-07-03 18:00 |
Post-Annual General Meeting Information
ΔΕΛΤΙΟ ΤΥΠΟΥ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
|
Greek (modern) | 123.4 KB | |
| 2025-07-03 18:00 |
Post-Annual General Meeting Information
PRESS RELEASE
|
English | 121.3 KB | |
| 2025-07-03 17:35 |
Post-Annual General Meeting Information
ΑΝΑΚΟΙΝΩΣΗ ΕΠΙΤΡΟΠΗΣ ΕΛΕΓΧΟΥ
|
Greek (modern) | 503.0 KB | |
| 2025-07-03 17:17 |
Board/Management Information
ΓΝΩΣΤΟΠΟΙΗΣΗ ΑΛΛΑΓΗΣ ΣΥΝΘΕΣΗΣ ΔΙΟΙΚΗΤΙΚΟΥ ΣΥΜΒΟΥΛΙΟΥ
|
Greek (modern) | 598.1 KB | |
| 2025-07-03 17:05 |
Post-Annual General Meeting Information
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
|
Greek (modern) | 195.1 KB | |
| 2025-06-11 16:30 |
Pre-Annual General Meeting Information
ΠΡΟΣΚΛΗΣΗ ΣΕ ΤΑΚΤΙΚΗ ΓΕΝΙΚΗ ΣΥΝΕΛΕΥΣΗ
|
Greek (modern) | 191.0 KB | |
| 2025-05-15 16:19 |
Earnings Release
Βασικά Οικονομικά Μεγέθη A Τριμήνου 2025
|
Greek (modern) | 118.2 KB | |
| 2025-05-15 16:19 |
Earnings Release
Financial Results Q1 2025
|
English | 92.6 KB | |
| 2025-04-24 16:39 |
Investor Presentation
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΕΝΗΜΕΡΩΣΗ ΕΙΣΗΓΜΕΝΗΣ ΠΡΟΣ ΑΝΑΛΥΤΕΣ
|
English | 1.0 MB | |
| 2025-04-24 16:39 |
Regulatory News Service
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΕΝΗΜΕΡΩΣΗ ΕΙΣΗΓΜΕΝΗΣ ΠΡΟΣ ΑΝΑΛΥΤΕΣ
|
Greek (modern) | 116.5 KB | |
| 2025-04-24 16:39 |
Investor Presentation
Annual Analists Briefing
|
English | 61.4 KB | |
| 2025-04-24 16:39 |
Investor Presentation
Annual Analists Briefing
|
English | 1.0 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |